Cargando…

A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer

The envelope protein of human immunodeficiency virus-1 (HIV-1) and its fusion peptide are essential for cell entry and vaccine design. Here, we describe the 3.9-Å resolution structure of an envelope protein trimer from a very early transmitted founder virus (CRF01_AE T/F100) complexed with Fab from...

Descripción completa

Detalles Bibliográficos
Autores principales: Ananthaswamy, Neeti, Fang, Qianglin, AlSalmi, Wadad, Jain, Swati, Chen, Zhenguo, Klose, Thomas, Sun, Yingyuan, Liu, Yue, Mahalingam, Marthandan, Chand, Subhash, Tovanabutra, Sodsai, Robb, Merlin L., Rossmann, Michael G., Rao, Venigalla B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382815/
https://www.ncbi.nlm.nih.gov/pubmed/30787293
http://dx.doi.org/10.1038/s41467-019-08825-7
_version_ 1783396724867334144
author Ananthaswamy, Neeti
Fang, Qianglin
AlSalmi, Wadad
Jain, Swati
Chen, Zhenguo
Klose, Thomas
Sun, Yingyuan
Liu, Yue
Mahalingam, Marthandan
Chand, Subhash
Tovanabutra, Sodsai
Robb, Merlin L.
Rossmann, Michael G.
Rao, Venigalla B.
author_facet Ananthaswamy, Neeti
Fang, Qianglin
AlSalmi, Wadad
Jain, Swati
Chen, Zhenguo
Klose, Thomas
Sun, Yingyuan
Liu, Yue
Mahalingam, Marthandan
Chand, Subhash
Tovanabutra, Sodsai
Robb, Merlin L.
Rossmann, Michael G.
Rao, Venigalla B.
author_sort Ananthaswamy, Neeti
collection PubMed
description The envelope protein of human immunodeficiency virus-1 (HIV-1) and its fusion peptide are essential for cell entry and vaccine design. Here, we describe the 3.9-Å resolution structure of an envelope protein trimer from a very early transmitted founder virus (CRF01_AE T/F100) complexed with Fab from the broadly neutralizing antibody (bNAb) 8ANC195. The overall T/F100 trimer structure is similar to other reported “closed” state prefusion trimer structures. In contrast, the fusion peptide, which is exposed to solvent in reported closed structures, is sequestered (buried) in the hydrophobic core of the T/F100 trimer. A buried conformation has previously been observed in “open” state structures formed after CD4 receptor binding. The T/F100 trimer binds poorly to bNAbs including the fusion peptide-specific bNAbs PGT151 and VRC34.01. The T/F100 structure might represent a prefusion state, intermediate between the closed and open states. These observations are relevant to mechanisms of HIV-1 transmission and vaccine design.
format Online
Article
Text
id pubmed-6382815
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-63828152019-02-22 A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer Ananthaswamy, Neeti Fang, Qianglin AlSalmi, Wadad Jain, Swati Chen, Zhenguo Klose, Thomas Sun, Yingyuan Liu, Yue Mahalingam, Marthandan Chand, Subhash Tovanabutra, Sodsai Robb, Merlin L. Rossmann, Michael G. Rao, Venigalla B. Nat Commun Article The envelope protein of human immunodeficiency virus-1 (HIV-1) and its fusion peptide are essential for cell entry and vaccine design. Here, we describe the 3.9-Å resolution structure of an envelope protein trimer from a very early transmitted founder virus (CRF01_AE T/F100) complexed with Fab from the broadly neutralizing antibody (bNAb) 8ANC195. The overall T/F100 trimer structure is similar to other reported “closed” state prefusion trimer structures. In contrast, the fusion peptide, which is exposed to solvent in reported closed structures, is sequestered (buried) in the hydrophobic core of the T/F100 trimer. A buried conformation has previously been observed in “open” state structures formed after CD4 receptor binding. The T/F100 trimer binds poorly to bNAbs including the fusion peptide-specific bNAbs PGT151 and VRC34.01. The T/F100 structure might represent a prefusion state, intermediate between the closed and open states. These observations are relevant to mechanisms of HIV-1 transmission and vaccine design. Nature Publishing Group UK 2019-02-20 /pmc/articles/PMC6382815/ /pubmed/30787293 http://dx.doi.org/10.1038/s41467-019-08825-7 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Ananthaswamy, Neeti
Fang, Qianglin
AlSalmi, Wadad
Jain, Swati
Chen, Zhenguo
Klose, Thomas
Sun, Yingyuan
Liu, Yue
Mahalingam, Marthandan
Chand, Subhash
Tovanabutra, Sodsai
Robb, Merlin L.
Rossmann, Michael G.
Rao, Venigalla B.
A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer
title A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer
title_full A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer
title_fullStr A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer
title_full_unstemmed A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer
title_short A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer
title_sort sequestered fusion peptide in the structure of an hiv-1 transmitted founder envelope trimer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382815/
https://www.ncbi.nlm.nih.gov/pubmed/30787293
http://dx.doi.org/10.1038/s41467-019-08825-7
work_keys_str_mv AT ananthaswamyneeti asequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT fangqianglin asequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT alsalmiwadad asequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT jainswati asequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT chenzhenguo asequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT klosethomas asequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT sunyingyuan asequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT liuyue asequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT mahalingammarthandan asequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT chandsubhash asequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT tovanabutrasodsai asequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT robbmerlinl asequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT rossmannmichaelg asequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT raovenigallab asequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT ananthaswamyneeti sequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT fangqianglin sequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT alsalmiwadad sequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT jainswati sequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT chenzhenguo sequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT klosethomas sequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT sunyingyuan sequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT liuyue sequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT mahalingammarthandan sequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT chandsubhash sequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT tovanabutrasodsai sequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT robbmerlinl sequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT rossmannmichaelg sequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer
AT raovenigallab sequesteredfusionpeptideinthestructureofanhiv1transmittedfounderenvelopetrimer